This site is intended for healthcare professionals only
LoginRegister
Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance OfficerUSFDA issues EIR for Biocon Bengaluru facility
AstraZeneca collaborates with CSPC Pharma focused on AI-enabled researchAstraZeneca, Daiichi Sankyo voluntarily withdraws datopotamab deruxtecan application in EU for lung...
Court denies bail to Khyati Hospital ChairmanNo Bail for Pharma Firm Owner Accused of Producing Spurious Drugs
Natco Pharma gets 7 USFDA observations for Kothur Pharma DivisionAarti Drugs gets USFDA EIR for Tarapur facility
Akums Drugs, Tamil Nadu Agricultural University collaborate for pharmaceutical innovationAkums Drugs ink pact with global pharma firm for production, supply of pharma formulations in...
Dr Reddys Gets CDSCO Panel Nod To Import, Market Saccharomyces Boulardii, BE, CT WaivedDr Reddy's Labs Switzerland incorporates new wholly-owned subsidiary in Finland
Rs 1.91 Crore spent on Doctors Travel: Pharma Company faces UCPMP heat, soon action against 30 doctorsRs 1.91 Crore spent on Doctors Travel: Pharma Company faces UCPMP heat, soon action against 30...
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibUSFDA revokes authorization of COVID antibody drugs of GSK, Lilly and 2 others
More Indian pharma cos to open innovative research in foreign countriesMore Indian pharma cos to open innovative research in foreign countries: Report
Biocon Biologics expands biosimilar insulin portfolio with USFDA nod of KirstyBiocon, Zentiva gets Decentralized Procedure approval for generic diabetes, weight management drug...
Novartis ianalumab Phase III trial meets primary endpoint in immune thrombocytopeniaCDSCO Panel Approves Novartis Protocol Amendment Proposal for Ianalumab Study
CDSCO Committee Calls for Stronger Action Against Fake Medicines, Stricter Quality ChecksOnly 5.9% Spurious Drug Cases Resolved: Parliamentary Panel Slams Govt
X